Pharmacy Practice and Clinical Pharmacy Research Discipline
Informing and influencing the practice of pharmacy and the development of policy around medicines usage and approval.
(Coordinator, Dai John )
Particular expertise in this discipline is in the development and application of health-related quality-of-life measures with which to evaluate the clinical effectiveness of various drug therapies in a number of diseases, such as Alzheimer’s-type dementia, multiple sclerosis, Parkinson’s disease and cancer. A composite measure of health status is employed to evaluate patient outcomes using two methodological approaches: firstly, through hypothesis testing studies such as randomised controlled trials and secondly, through the routine application of quality-of-life measures in clinical decision-making (including prescribing) and patient monitoring.
Other research expertise includes the development of models for benefit/risk assessment of medicines, drug treatment decision support systems, and issues relating to global pharmaceutical development and its regulation.
Current research interests include:
- Pharmacoepidemiology
- Pharmacovigilance
- Patient communication; Decision-making
- Pharmaceutical public health
- Pharmacy education, training and professional development
- Pharmaceutical regulatory environment and drug development
162.0 KbHighlight News
01/06/2011
Third year PhD student, Catherine Golics, presented a key paper at the 14th Congress of the European Society for Dermatology and Psychiatry in Zaragoza, Spain March 17-19th 2011
07/12/2009
Dai John honoured for 'distinction in the practice & profession of pharmacy'